Black Rock Inc. Tff Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.31 - $0.48 $252 - $390	-813 Reduced 0.38%	213,085 $74,000
Q2 2023 Aug 11, 2023	SELL	$0.43 - $0.77 $25,603 - $45,848	-59,543 Reduced 21.78%	213,898 $100,000
Q1 2023 May 12, 2023	BUY	$0.62 - $1.1 $8,463 - $15,016	13,651 Added 5.25%	273,441 $185,000
Q4 2022 Feb 13, 2023	BUY	$0.84 - $100.75 $549 - $65,890	654 Added 0.25%	259,790 $272,000
Q3 2022 Nov 14, 2022	SELL	$4.61 - $116.0 $8,546 - $215,064	-1,854 Reduced 0.71%	259,136 $1.05 Million
Q2 2022 Aug 12, 2022	BUY	$3.99 - $7.22 $13,246 - $23,970	3,320 Added 1.29%	260,990 $1.48 Million
Q1 2022 May 12, 2022	BUY	$5.28 - $9.17 $902 - $1,568	171 Added 0.07%	257,670 $1.63 Million
Q4 2021 Feb 10, 2022	SELL	$6.86 - $9.65 $12,149 - $17,090	-1,771 Reduced 0.68%	257,499 $2.28 Million
Q3 2021 Nov 09, 2021	SELL	$7.21 - $10.49 $16,179 - $23,539	-2,244 Reduced 0.86%	259,270 $2 Million
Q2 2021 Aug 11, 2021	BUY	$8.48 - $13.61 $2.22 Million - $3.56 Million	261,514 New	261,514 $2.51 Million

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.66M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.